GNRH1 and prostate carcinoma: The GnRH agonists, triptorelin, decapeptyl GnRH and goserelin, exerted cytotoxic effects on ovarian or endometrial cancer cells, whereas the growth rate of prostate cancer cells was decreased by both leuprolide and triptorelin [22,25,30,31,65,66,67].